Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

HBIOHBIO
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in HARVARD BIOSCIENCE INC

BNP PARIBAS FINANCIAL MARKETS holds 66 shares of HBIO (HARVARD BIOSCIENCE INC), worth $406 as of 2026-Q2. The position was decreased (-2.9% shares).

Current Value

$406

Current Shares

66

Total Value Change

-$200,472

Total Shares Change

-74,610

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
66
-2.9%
$4060.0%$6.15
0
2026-Q1
Decreased
68
-90.0%
$3310.0%$4.87
0
2025-Q4
Unchanged
680
0.0%
$4550.0%$6.70
0
2025-Q3
Decreased
680
-61.2%
$2980.0%$4.40
0
2025-Q2
Decreased
1,753
-97.2%
$7780.0%$4.40
0
2025-Q1
Decreased
62,301
-5.9%
$35,2620.0%$5.70
0
2024-Q4
Decreased
66,204
-11.3%
$139,6900.0%$21.10
0
2024-Q3
Decreased
74,676
-28.9%
$200,8780.0%$26.90
0

Other major holders of HBIO: ROYCE & ASSOCIATES LP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used